• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于痘苗的天花疫苗的小鼠神经毒性试验。

Mouse neurotoxicity test for vaccinia-based smallpox vaccines.

作者信息

Li Zhongqi, Rubin Steven A, Taffs Rolf E, Merchlinsky Michael, Ye Zhiping, Carbone Kathryn M

机构信息

Laboratory of Pediatric and Respiratory Viral Diseases, OD/Center for Biologics Evaluation and Research, Food and Drug Administration, HFM-460, Bldg. 29B, Room 5NN22, 8800 Rockville Pike, Bethesda, MD 20892, USA.

出版信息

Vaccine. 2004 Mar 29;22(11-12):1486-93. doi: 10.1016/j.vaccine.2003.10.022.

DOI:10.1016/j.vaccine.2003.10.022
PMID:15063573
Abstract

The only US FDA licensed smallpox vaccine, Dryvax, was associated with rare but serious neurological adverse events. After smallpox was eradicated in the United States, mass vaccination ceased in 1971. As counter-bioterrorism/biowarfare measures, new smallpox vaccines are now being investigated. However, there are no established pre-clinical neurotoxicity assays with which to evaluate these new vaccines prior to licensure. Here we report the development and initial characterization of a small animal neurotoxicity assay for vaccinia-based smallpox vaccines using Dryvax virus as a reference vaccine strain and the neuroadapted Western Reserve (WR) strain as a neurotoxic positive control. In neonatally inoculated mice, the WR strain produced significantly greater and more rapid onset of mortality than the Dryvax vaccine reference. Expression of virus antigen in neural cells and infectious virus replication in the brain was also significantly different between the two strains. In addition, the appearance of high titer virus antibody correlated with the clearance of virus from brain. With further validation, this assay incorporating a licensed vaccine reference standard and positive control strain may provide important pre-clinical neurotoxicity data on new vaccinia-based smallpox vaccine strains.

摘要

美国食品药品监督管理局(FDA)唯一批准的天花疫苗Dryvax,与罕见但严重的神经不良事件相关。在美国消灭天花后,大规模疫苗接种于1971年停止。作为反生物恐怖主义/生物战措施,新型天花疫苗目前正在研究中。然而,在疫苗获批之前,尚无成熟的临床前神经毒性检测方法来评估这些新型疫苗。在此,我们报告了一种针对基于痘苗的天花疫苗的小动物神经毒性检测方法的开发及初步特性研究,该方法使用Dryvax病毒作为参考疫苗株,并使用神经适应性西方储备(WR)株作为神经毒性阳性对照。在新生小鼠中,WR株比Dryvax疫苗参考株导致显著更高且更迅速的死亡。两种毒株在神经细胞中的病毒抗原表达以及脑中的感染性病毒复制也存在显著差异。此外,高滴度病毒抗体的出现与脑中病毒的清除相关。通过进一步验证,这种纳入了获批疫苗参考标准和阳性对照株的检测方法,可能会为新型基于痘苗的天花疫苗株提供重要的临床前神经毒性数据。

相似文献

1
Mouse neurotoxicity test for vaccinia-based smallpox vaccines.基于痘苗的天花疫苗的小鼠神经毒性试验。
Vaccine. 2004 Mar 29;22(11-12):1486-93. doi: 10.1016/j.vaccine.2003.10.022.
2
Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.在小鼠模型中,用改良安卡拉痘苗病毒和已获许可的天花疫苗Dryvax联合接种所赋予的增强免疫原性和保护作用。
Virology. 2005 Sep 1;339(2):164-75. doi: 10.1016/j.virol.2005.06.002.
3
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.痘苗免疫球蛋白识别的痘苗病毒(Dryvax)抗原的鉴定及初步表征
Virology. 2005 Dec 5;343(1):128-40. doi: 10.1016/j.virol.2005.08.008. Epub 2005 Sep 13.
4
Vaccinia virus-induced smallpox postvaccinal encephalitis in case of blood-brain barrier damage.天花疫苗引发的牛痘后脑炎在血脑屏障损伤的情况下。
Vaccine. 2012 Feb 8;30(7):1397-405. doi: 10.1016/j.vaccine.2011.08.116. Epub 2012 Jan 9.
5
Tail scarification with Vaccinia virus Lister as a model for evaluation of smallpox vaccine potency in mice.以痘苗病毒李斯特株进行尾部划痕接种作为评估小鼠天花疫苗效力的模型。
Vaccine. 2007 Nov 7;25(45):7743-53. doi: 10.1016/j.vaccine.2007.09.023. Epub 2007 Sep 29.
6
[Development of a numerically additive combined vaccine against tetanus and smallpox].[一种针对破伤风和天花的数字相加联合疫苗的研发]
Zentralbl Bakteriol Mikrobiol Hyg A. 1985 Apr;259(2):206-18.
7
Clonal vaccinia virus grown in cell culture as a new smallpox vaccine.在细胞培养中生长的克隆痘苗病毒作为一种新型天花疫苗。
Nat Med. 2003 Sep;9(9):1125-30. doi: 10.1038/nm916. Epub 2003 Aug 17.
8
A mouse-based assay for the pre-clinical neurovirulence assessment of vaccinia virus-based smallpox vaccines.一种基于小鼠的用于痘苗病毒天花疫苗临床前神经毒力评估的检测方法。
Biologicals. 2010 Mar;38(2):278-83. doi: 10.1016/j.biologicals.2009.09.007. Epub 2009 Nov 6.
9
Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3.来自Dryvax天花疫苗的痘苗病毒克隆的基因组差异:类似Dryvax的ACAM2000和小鼠神经毒力克隆-3。
Vaccine. 2007 Dec 17;25(52):8807-32. doi: 10.1016/j.vaccine.2007.10.040. Epub 2007 Nov 8.
10
Highly attenuated smallpox vaccine protects rabbits and mice against pathogenic orthopoxvirus challenge.高度减毒的天花疫苗可保护兔和小鼠免受致病性正痘病毒的攻击。
Vaccine. 2006 Apr 24;24(17):3686-94. doi: 10.1016/j.vaccine.2005.03.029.

引用本文的文献

1
A comprehensive preclinical study supporting clinical trial of oncolytic chimeric poxvirus CF33-hNIS-anti-PD-L1 to treat breast cancer.一项支持溶瘤嵌合痘病毒CF33-hNIS-抗PD-L1治疗乳腺癌临床试验的全面临床前研究。
Mol Ther Methods Clin Dev. 2021 Dec 6;24:102-116. doi: 10.1016/j.omtm.2021.12.002. eCollection 2022 Mar 10.
2
Effect of Serial Passage on the Pathogenicity and Immunogenicity of Vaccinia Virus LC16m8 Strain.连续传代对痘苗病毒LC16m8株致病性和免疫原性的影响
Biology (Basel). 2021 Nov 9;10(11):1158. doi: 10.3390/biology10111158.
3
Enhancing the Protective Immune Response to Administration of a LIVP-GFP Live Attenuated Vaccinia Virus to Mice.
增强小鼠对LIVP-GFP减毒活痘苗病毒接种的保护性免疫反应。
Pathogens. 2021 Mar 21;10(3):377. doi: 10.3390/pathogens10030377.
4
Recombinant HIV-1 vaccine candidates based on replication-defective flavivirus vector.基于复制缺陷型黄病毒载体的重组 HIV-1 候选疫苗。
Sci Rep. 2019 Dec 27;9(1):20005. doi: 10.1038/s41598-019-56550-4.
5
Differential Response Following Infection of Mouse CNS with Virulent and Attenuated Vaccinia Virus Strains.用强毒和减毒痘苗病毒株感染小鼠中枢神经系统后的差异反应。
Vaccines (Basel). 2019 Feb 12;7(1):19. doi: 10.3390/vaccines7010019.
6
Attenuation of Vaccinia Virus.痘苗病毒的减毒
Acta Naturae. 2015 Oct-Dec;7(4):113-21.
7
Virological and immunological characterization of novel NYVAC-based HIV/AIDS vaccine candidates expressing clade C trimeric soluble gp140(ZM96) and Gag(ZM96)-Pol-Nef(CN54) as virus-like particles.表达C亚型三聚体可溶性gp140(ZM96)和Gag(ZM96)-Pol-Nef(CN54)作为病毒样颗粒的新型基于NYVAC的HIV/AIDS候选疫苗的病毒学和免疫学特性
J Virol. 2015 Jan 15;89(2):970-88. doi: 10.1128/JVI.02469-14. Epub 2014 Oct 29.
8
Improved NYVAC-based vaccine vectors.改良基于 NYVAC 的疫苗载体。
PLoS One. 2011;6(11):e25674. doi: 10.1371/journal.pone.0025674. Epub 2011 Nov 9.
9
Attenuated NYCBH vaccinia virus deleted for the E3L gene confers partial protection against lethal monkeypox virus disease in cynomolgus macaques.E3L 基因缺失的弱毒 NYCBH 痘苗病毒可部分保护食蟹猴免受致命猴痘病毒病的侵害。
Vaccine. 2011 Dec 6;29(52):9684-90. doi: 10.1016/j.vaccine.2011.09.135. Epub 2011 Oct 12.
10
The attenuated NYCBH vaccinia virus deleted for the immune evasion gene, E3L, completely protects mice against heterologous challenge with ectromelia virus.减毒 NYCBH 牛痘病毒缺失了免疫逃逸基因 E3L,可完全保护小鼠免受异源水疱性口炎病毒的攻击。
Vaccine. 2011 Dec 6;29(52):9691-6. doi: 10.1016/j.vaccine.2011.09.108. Epub 2011 Oct 5.